Maine § 5 §2048 Annual reporting

Maine Statutes

§ 5 §2048 — Annual reporting

Maine § 5 §2048

Title 5ADMINISTRATIVE PROCEDURES AND SERVICES

Part 4FINANCE

Ch. 168WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM

This text of Maine § 5 §2048 (Annual reporting) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 5, § 5 §2048 (2026).

Text

Beginning January 2021, and annually thereafter, the Department of Health and Human Services, or other state agency designated to oversee the program pursuant to this chapter, shall report to the joint standing committee of the Legislature having jurisdiction over health coverage and prescription drugs regarding the implementation and operation of the program during the previous calendar year, including:

1.Prescription drugs included. The prescription drugs included in the program;

2.Participation. The number of participating pharmacies, health care providers and health insurance carriers;

3.Prescriptions dispensed. The number of prescription drugs dispensed through the program;

4.Estimated savings. The estimated cost savings to consumers, health insurance carriers, employers and the S

Free access — add to your briefcase to read the full text and ask questions with AI

Beginning January 2021, and annually thereafter, the Department of Health and Human Services, or other state agency designated to oversee the program pursuant to this chapter, shall report to the joint standing committee of the Legislature having jurisdiction over health coverage and prescription drugs regarding the implementation and operation of the program during the previous calendar year, including:
1.
Prescription drugs included.
The prescription drugs included in the program;
2.
Participation.
The number of participating pharmacies, health care providers and health insurance carriers;
3.
Prescriptions dispensed.
The number of prescription drugs dispensed through the program;
4.
Estimated savings.
The estimated cost savings to consumers, health insurance carriers, employers and the State during the previous calendar year and to date;
5.
Audit findings.
Information regarding implementation of the audit work plan and audit findings; and
6.
Other relevant information.
Any other information the Department of Health and Human Services, or other state agency designated to oversee the program pursuant to this chapter, considers relevant.